GL1X · GenesisL1 explorer

UniProt Q68CP4

Heparan-alpha-glucosaminide N-acetyltransferase (Q68CP4)

Heparan-alpha-glucosaminide N-acetyltransferase (UniProt Q68CP4), EC 2.3.1.78: 8 experimental structures on GenesisL1, 10 ligands bound, 114 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
Q68CP4
Protein
Heparan-alpha-glucosaminide N-acetyltransferase
EC
2.3.1.78
Experimental structures
8
Predicted models
0
Ligands
10
Pockets
114 · 7 records with a druggable one

Structures

8 records of Q68CP4 in the MolNFT archive: 8 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
8JL1membrane proteinselectron microscopyA, BNAG, ACO, D12, C14, CLR, D1016 (best 0.83)
8JL3membrane proteinselectron microscopyA, BNAG, ACO, D12, C14, CLR, D1017 (best 0.83)
8JL4membrane proteinselectron microscopyA, BNAG, UV6, COA, C14, CLR, D1019 (best 0.83)
8TU9Cryo-EM structure of HGSNAT-acetyl-CoA complex at pH 7.5electron microscopyA, BACO, NAG20 (best 0.84)
8VLVCryo-EM structure of human HGSNAT in inactive stateelectron microscopyA, BNAG15 (best 0.78)
8VLYCryo-EM structure of human HGSNAT in transition stateelectron microscopyA, BNAG12 (best 0.77)
8W4Amembrane proteinselectron microscopyB, ANAG, UV6, ACO, C14, CLR, D1015 (best 0.83)
Q68CP4AlphaFold monomer V2.0 prediction for heparan-alpha-glucosaminide N-acetyltransferase (Q68CP4)———

Ligands

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · in 7 records
  • ACO · Acetyl coenzyme *A · in 4 records
  • C14 · Tetradecane · in 4 records
  • CLR · Cholesterol · in 4 records
  • D10 · Decane · in 4 records
  • D12 · Dodecane · in 4 records
  • R16 · Hexadecane · in 4 records
  • HP6 · Heptane · in 2 records
  • UV6 · ~{N}-[(2~{S},3~{R},4~{R},5~{S},6~{R})-6-(hydroxymethyl)-2-[[(2~{R},4~{R})-4-methyl-2-oxidanyl-3,4-dihydro-2~{H}-chromen-7-yl]oxy]-4,5-bis(oxidanyl)oxan-3-yl]ethanamide · in 2 records
  • COA · Coenzyme A · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.